On 15 January 2019, Professor Kevin Outterson, executive director of CARB-X, will be featured in a webinar to introduce and explain the public-private partnership CARB-X, which is dedicated to the early development of innovative antibiotics, vaccines, and other products to fight superbugs.

Find more information and a registration link here.